Research on innate immunity, airway remodeling, and epigenetic reprogramming
Dr. Allan Brasier is a physician-investigator internationally recognized for his scholarship in innate inflammation, with 240 peer-reviewed publications being cited in over 10,702 citations (H index of 59, i10 of 130, Google Scholar) each receiving an average of over 40.5 citations (Web of Science). He actively participates in NIH peer review as recent chair of NIAID Special Emphasis Panel on Food Allergy, active member of NIGMS-IDeA-CTR, LCMI and NHLBI SMARTT review panels. He has served for 6 years on Experimental Virology (2 as chair) study sections.
Dr. Brasier has over 16 years of experience leading and managing complex multicomponent research programs. He served for10 years as the founding Director for the Institute for Translational Sciences and PI of University of Texas Medical Branch’s CTSA for two funding cycles. During his tenure, the ITS implemented transformational training programs including KL2, TL1, and certificate programs in systems biology, team management/leadership and patient centered outcomes research. In his current role at the University of Wisconsin-Madison, he serves as the Executive Director of the UW Institute for Clinical and Translational Research (ICTR), and contact PI of its CTSA award in a multiple PD/PI program (with Dr. Elizabeth Burnside). He is active in transforming the landscape of translational research and promoting multidisciplinary team science.